Codiak Biosciences Inc. (CDAK) PT Raised to $34 at Wedbush, Following Earnings

March 17, 2021 1:21 PM EDT
Get Alerts CDAK Hot Sheet
Price: $17.68 -0.56%

Rating Summary:
    3 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 11 | New: 8
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Wedbush analyst David Nierengarten raised the price target on Codiak Biosciences Inc. (NASDAQ: CDAK) to $34.00 (from $31.00) while maintaining a Outperform rating.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change

Related Entities